DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DesignMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10591
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that provides cure for drug-resistant malaria to vulnerable patients including children and pregnant women. DesignMedix’s DM1157 product overcomes drug resistance in blood samples from patients infected with drug-resistant malaria parasites. The company’s malaria preventive drugs provide novel therapeutic agents that are used in prevention of liver-stage malaria in a mouse model. DesignMedix is headquartered in Portland, Oregon, the US.

DesignMedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DesignMedix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
DesignMedix Raises USD0.7 Million in Venture Financing 10
DesignMedix Raises USD1.5 Million in Venture Financing 11
DesignMedix Raises USD0.53 Million in Venture Financing 12
Partnerships 13
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 13
Licensing Agreements 14
DesignMedix Enters into Licensing Agreement with University of California, San Diego 14
DesignMedix Inc – Key Competitors 15
DesignMedix Inc – Key Employees 16
DesignMedix Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
DesignMedix Inc, Pharmaceuticals & Healthcare, Key Facts 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DesignMedix Raises USD0.7 Million in Venture Financing 10
DesignMedix Raises USD1.5 Million in Venture Financing 11
DesignMedix Raises USD0.53 Million in Venture Financing 12
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 13
DesignMedix Enters into Licensing Agreement with University of California, San Diego 14
DesignMedix Inc, Key Competitors 15
DesignMedix Inc, Key Employees 16

List of Figures
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Robert Half International Inc (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • HiQ International AB (HIQ):企業の財務・戦略的SWOT分析
    Summary HiQ International AB (HiQ International) is a technology and communication company that offers management consultancy services. The company offers communication solutions, development of software, and business-critical IT systems. It provides services in the areas of telecom media, gaming an …
  • ASUSTeK Computer Inc.:企業の戦略・SWOT・財務情報
    ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report Summary ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vitasoy International Holdings Ltd.:企業の戦略・SWOT・財務分析
    Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Toho Gas Co Ltd (9533):企業の財務・戦略的SWOT分析
    Toho Gas Co Ltd (9533) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報
    Summary Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotid …
  • ProMetic Life Sciences Inc (PLI):製薬・医療:M&Aディール及び事業提携情報
    Summary ProMetic Life Sciences Inc (ProMetic) is a biopharmaceutical company that focuses on bioseparations, plasma-derived therapeutics and small-molecule drug development. The company develop products for the treatment for fibrosis, anemia, autoimmune diseases, inflammation and nephropathies. The …
  • Discovery Communications, Inc.:企業の戦略・SWOT・財務情報
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • ERHC Energy Inc (ERHE):企業の財務・戦略的SWOT分析
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • MorphoSys AG (MOR):製薬・医療:M&Aディール及び事業提携情報
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product includes MOR208, MOR202, MOR103, MOR106, and MOR107. It drugs are used for the treatment of various types of cancers, psoriasis, rheumatoid a …
  • Chevron Corporation:企業の戦略・SWOT・財務情報
    Chevron Corporation - Strategy, SWOT and Corporate Finance Report Summary Chevron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mars Incorporated:企業の戦略的SWOT分析
    Mars Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PZ Cormay SA (CRM):医療機器:M&Aディール及び事業提携情報
    Summary PZ Cormay SA (Cormay) is a medical device company that produces and wholesale diagnostic reagents and laboratory equipment. The company provides products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipm …
  • Ingram Micro Inc:企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tommy Hilfiger Licensing LLC:企業の戦略・SWOT・財務情報
    Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report Summary Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆